Cite
HARVARD Citation
Becker-Dreps, S. et al. (2022). Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children. Journal of the Pediatric Infectious Diseases Society. 11 (10), pp. 459-462. [Online].